0001062993-23-023027.txt : 20231221 0001062993-23-023027.hdr.sgml : 20231221 20231221160433 ACCESSION NUMBER: 0001062993-23-023027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weber Kathleen Gallagher CENTRAL INDEX KEY: 0001756089 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16537 FILM NUMBER: 231505291 MAIL ADDRESS: STREET 1: 220 EAST FIRST STREET CITY: BETHLEHEM STATE: PA ZIP: 18017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORASURE TECHNOLOGIES INC CENTRAL INDEX KEY: 0001116463 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 364370966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 220 E FIRST ST CITY: BETHLEHEM STATE: PA ZIP: 18015 BUSINESS PHONE: 5036416115 MAIL ADDRESS: STREET 1: 220 E FIRST ST CITY: BETHLEHEM STATE: PA ZIP: 18015 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-19 0001116463 ORASURE TECHNOLOGIES INC OSUR 0001756089 Weber Kathleen Gallagher C/O ORASURE TECHNOLOGIES, INC. 220 EAST FIRST STREET BETHLEHEM PA 18015 0 1 0 0 Chief Product Officer 1 Common Stock 2023-12-19 4 M 0 4129 5.7149 A 278829 D Common Stock 2023-12-19 4 S 0 24129 8.0492 D 254700 D Non-Qualified Stock Options 5.7149 2023-12-19 4 M 0 4129 0 D 2024-02-03 Common Stock 4129 0 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.095, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Non-qualified stock options granted on February 3, 2014, vesting 25% at the end of 12 months after the grant date and 75% ratably on a monthly basis over the next 36 months. Vesting shall cease upon voluntary termination of employment. /s/ Michele Anthony, Attorney-In-Fact 2023-12-21